The short version of REV-ERB agonist fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-13 and is reviewed periodically as new material appears.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
According to the 2015–2016 Association of Research Libraries' "Spending by University Research Libraries" report, UA libraries are ranked as the 37th overall university library in North America (out of 114) for university investment. As of 2012, the UA's library system contains over six million print volumes, 1.1 million electronic books, and 74,000 electronic journals. The Main Library, opened in 1976, serves as the library system's reference, periodical, and administrative center; most of the main collections are housed here. The Main Library is on the southeast quadrant of campus near McKale Center and Arizona Stadium. In 2002, the Integrated Learning Center (ILC) was completed as a $20 million, 100,000-square-foot (10,000 m2) computer facility intended for use by incoming students. The ILC features classrooms, auditoriums, a courtyard with vending machines, and an expanded computer lab with several dozen workstations and 3D printing. Computers and 3D printing are available for use by the general public (with some restrictions) as well as by UA students, faculty and staff. The Arizona Health Sciences Library, built in 1996, is on the Health Sciences Center on the north end of campus and on the Phoenix Biomedical Campus, in the Health Sciences Education Building (HSEB). The library serves the Colleges of Medicine, Nursing, Pharmacy, Public Health, and Veterinary Medicine, the University of Arizona Health Network, and is a resource for health professionals and citizens across the state. An important part of the Main Library is the Special Collections library.
== Related compounds == Numerous other compounds similar to levonantradol were also developed at the same time, including CP 42,096, CP 47,497, CP 55,940 and CP 55,244. The desacetyl derivative of levonantradol (DALN or CP 54,939) and its N-methyl derivative, as well as the tetracyclic analogue all have similar activity to levonantradol itself.
The Global Carbon Budget 2021 concludes that fossil CO2 emissions rebounded by around +4.8% relative to 2020 emissions – returning to 2019 levels, identifies three major issues for improving reliable accuracy of monitoring, shows that China and India surpassed 2019 levels (by 5.7% and 3.2%) while the EU and the US stayed beneath 2019 levels (by 5.3% and 4.5%), quantifies various changes and trends, for the first time provides models' estimates that are linked to the official country GHG inventories reporting, and shows that the remaining carbon budget at 1. Jan 2022 for a 50% likelihood to limit global warming to 1.5 °C is 120 GtC (420 GtCO2) – or 11 years of 2021 emissions levels. Scientists propose and preliminarily evaluate a likely transgressed planetary boundary for green water in the water cycle, measured by root-zone soil moisture deviation from Holocene variability. A study published one day earlier integrates "green water" along with "blue water" into an index to measure and project water scarcity in agriculture for climate change scenarios. 27 April A lineage of H3N8 bird flu is found to infect humans for the first time, with a case reported in the Henan province of China. Months earlier, H5 strain bird flu viruses (HPAIv) have been detected in Canada and the US. A study extends global assessments of shares of species threatened by extinction with reptiles, which often play functional roles in their respective ecosystems, indicating at least 21% are threatened by extinction.
The PBI operated by using a helium gas nebulizer to spray the eluant into the vacuum, drying the droplets and pumping away the solvent vapour (using a jet separator) while the stream of monodisperse dried particles containing the analyte entered the source. Drying the droplets outside of the source volume, and using a jet separator to pump away the solvent vapour, allowed the particles to enter and be vapourized in a low-pressure EI source. As with the MBI, the ability to generate library-searchable EI spectra was a distinct advantage for many applications. Commercialized by Hewlett Packard, and later by VG and Extrel, it enjoyed moderate success, but has been largely supplanted by the atmospheric pressure interfaces such as electrospray and APCI which provide a broader range of compound coverage and applications.
=== The Ait Soussan organisation === The Ait Soussan organisation is a criminal organisation led by Houssine Ait Soussan. He is a major drug trafficker who also used to own the Dutch football-club ZVV 't Knooppunt. Houssine Ait Soussan is notably a prominent figure within the Moroccan mafia in the Netherlands and Belgium, and he was also allied with the Bouyakhrichan organisation. The Ait Soussan organisation is responsible for distributing tons of cocaine across all of Western Europe. Houssine Ait Soussan is also considered to be one of the original participating figures within the Mocro-War, which was sparked after a missing shipment of cocaine in the port of Antwerp. As a result of this, Houssine Ait Soussan is believed to be behind the kidnapping of Abdelkader "the Jew" Bouker, a major Belgian-Moroccan drug trafficker who worked closely together with the Israeli mafia, and went missing in 2016. He was also believed to be behind the kidnapping of Younes El Ballouti, the younger brother of Othman El Ballouti, who is considered to be one of the biggest drug lords in Belgium. Houssine Ait Soussan allegedly kidnapped him as revenge, because Colombian cartels preferred to work with the El Ballouti clan instead of his organisation. Houssine Ait Soussan was for many years wanted by the Dutch and Belgian authorities for his involvement in numerous of assassinations and kidnappings, which mostly took place in Antwerp and Brussels. He orchestrated his kidnappings and assassinations from Central America, to stay off the radar from the European police.
Sources: en.wikipedia.org
=== Electronized Chemicals Corporation === In 1943, Arno Brasch and Wolfgang Huber built a bespoke particle accelerator in Brooklyn, New York to irradiate foods, finding they could sterilize foods without affecting their taste. Brash and Huber founded Electronized Chemicals Corporation to explore methods for cold sterilization. HVEC acquired their company in 1957 and began to broadly explore radiation processing of materials. Using HVEC's electron beam technology at a facility adjoining the HVEC Burlington plant, ECC's new operation in Burlington rented irridiation services to a variety of industries. It developed methods to irradiate and crosslink polymers. After Raychem pioneered a cross-linking method using low-voltage radiation in 1957, Electronized Chemicals followed it into the manufacture of heat-shrink tubing. In 1985, the business was acquired by 3M, which continues to manufacture heat-shrink tubing a factory in Chelmsford, Massachusetts.
=== Writing career === After writing several short stories, a novella and book reviews, his debut crime novel, Dead I Well May Be, was published by Scribner in 2003. The book was followed by two sequels in what would become to be known as the Michael Forsythe Trilogy. Alongside these, McKinty wrote the three books in his Lighthouse Trilogy, a series of science fiction young adult novels set in New York City, his native Ireland, and the fictional planet Altair. In 2008 McKinty moved with his family to Melbourne, Australia, to become a full-time writer. He found his greatest success and critical acclaim with the Sean Duffy series, following the eponymous Royal Ulster Constabulary Sergeant during The Troubles, beginning with 2012's The Cold Cold Ground. In 2019, the author made this comment about that novel: "It didn't sell very well, but it ended up getting the best reviews of my career. I got shortlisted for an Edgar, won a couple of awards, and so then that set me on that path for the next six years of reluctantly, kind of being dragged into writing about Northern Ireland in the 1980s". The third Duffy book, In the Morning I'll Be Gone, won the 2014 Ned Kelly Award for Best Novel. McKinty has been an especially astute observer of class in fiction. He also began working as a writer and reviewer for a number of publications including The Guardian, The Sydney Morning Herald, The Washington Post, The Independent, The Australian, The Irish Times and Harpers.
=== Viscosity === The rheology of nanocellulose dispersions has been investigated. and revealed that the storage and loss modulus were independent of the angular frequency at all nanocellulose concentrations between 0.125% to 5.9%. The storage modulus values are particularly high (104 Pa at 3% concentration) compared to results for CNCs (102 Pa at 3% concentration). There is also a strong concentration dependence as the storage modulus increases 5 orders of magnitude if the concentration is increased from 0.125% to 5.9%. Nanocellulose gels are also highly shear thinning (the viscosity is lost upon introduction of the shear forces). The shear-thinning behaviour is particularly useful in a range of different coating applications. It is pseudo-plastic and exhibits thixotropy, the property of certain gels or fluids that are thick (viscous) under normal conditions, but become less viscous when shaken or agitated. When the shearing forces are removed the gel regains much of its original state.
=== Youth === The top three riders in the final results of each World Tour event's young rider classification received points towards the standings. Six points were awarded to first place, four points to second place and two points to third place.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.